Trials / Completed
CompletedNCT02083107
Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss
COMPARISON BETWEEN RECTAL & SUBLINGUAL MISOPROSTOL BEFORE CAESARIAN SECTION TO REDUCE INTRA & POST-OPERATIVE BLOOD LOSS
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 636 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Accepted
Summary
The aim of the work is to evaluate \& compare the effectiveness of rectally administered PGE1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before caesarean section to decrease blood loss during and after the operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | Comparison of different routes of administration of 400 micro gram misoprostol |
| OTHER | Placebo |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2014-03-11
- Last updated
- 2015-12-22
- Results posted
- 2014-06-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02083107. Inclusion in this directory is not an endorsement.